Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer-associated fibroblasts (CAFs) are a heterogeneous population of activated fibroblasts found within the tumor microenvironment. They acquire pro-tumorigenic properties that support cancer progression through multiple mechanisms, including extracellular matrix remodeling, promotion of angiogenesis, immune modulation, support of cancer stemness, and contribution to therapy resistance. CAFs are being actively investigated as therapeutic targets.
Inhibition of key signaling pathways involved in activation/function or targeting specific surface proteins unique to CAF subpopulations for drug delivery or depletion therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer-Associated Fibroblast (CAF).